Correlation Between Neurocrine Biosciences and Teva Pharma

Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Teva Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Teva Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurocrine Biosciences and Teva Pharma Industries, you can compare the effects of market volatilities on Neurocrine Biosciences and Teva Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Teva Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Teva Pharma.

Diversification Opportunities for Neurocrine Biosciences and Teva Pharma

0.59

Correlation Coefficient

Neurocrine Biosciences  Teva Pharma

Very weak diversification

The 3 months correlation between Neurocrine and Teva is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Teva Pharma Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Teva Pharma Industries and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Teva Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Teva Pharma Industries has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Teva Pharma go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and Teva Pharma

Given the investment horizon of 90 days Neurocrine Biosciences is expected to under-perform the Teva Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Neurocrine Biosciences is 1.54 times less risky than Teva Pharma. The stock trades about -0.01 of its potential returns per unit of risk. The Teva Pharma Industries is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  1,681  in Teva Pharma Industries on November 19, 2024 and sell it today you would lose (56.00) from holding Teva Pharma Industries or give up 3.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Neurocrine Biosciences  vs.  Teva Pharma Industries

Neurocrine Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Neurocrine Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong forward indicators, Neurocrine Biosciences is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Teva Pharma Industries

Risk-Adjusted Performance

Very Weak

Over the last 90 days Teva Pharma Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Teva Pharma is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Neurocrine Biosciences and Teva Pharma

The main advantage of trading using opposite Neurocrine Biosciences and Teva Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Teva Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Teva Pharma will offset losses from the drop in Teva Pharma's long position.

The idea behind Neurocrine Biosciences and Teva Pharma Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.